 Biomarin Pharmaceutical, Inc. NASDAQ:BMRN Q3 2022 Earnings Conference Call October 26, 2022 4:30 PM ET Company Participants Traci McCarty - VP, IR J.J. Bienaime - Chairman CEO Jeffrey Ajer - EVP Chief Commercial Officer Henry Fuchs - President, Worldwide Research Development Brian Mueller - EVP, Finance CFO Conference Call Participants Philip Nadeau - Cowen and Company Salveen Richter - Goldman Sachs Jessica Fye - JPMorgan Chase Co. Srikripa Devarakonda - Truist Securities Paul Matteis - Stifel, Nicolaus Company Robert Finke - Guggenheim Securities Joseph Schwartz - SVB Securities Lachlan Brown - William Blair Company Gena Wang - Barclays Bank Joel Beatty - Robert W. 